journal article·2013-06-25

Manipulation of in Vitro Angiogenesis Using Peptide-Coated Gold Nanoparticles

Dorota Bartczak, Otto L. Muskens, Tilman Sanchez-Elsner, Antonios G. Kanaras, Timothy M. Millar

ACS Nano· Volume 7· Issue 6
Publisher page

Abstract

We demonstrate the deliberate activation or inhibition of invitro angiogenesis using functional peptide coated gold nanoparticles. The peptides, anchored to oligo-ethylene glycol capped gold nanospheres, were designed to selectively interact with cell receptors responsible for activation or inhibition of angiogenesis. The functional particles are shown to influence significantly the extent and morphology of vascular structures, without causing toxicity. Mechanistic studies show that the nanoparticles have the ability to alter the balance between naturally secreted pro- and anti-angiogenic factors, under various biological conditions. Nanoparticle-induced control over angiogenesis opens up new directions in targeted drug delivery and therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Life Sciences, Physics and Astronomy, Faculty of Physical Sciences and Engineering, University of Southampton, SO17 1BJ, U.K.

Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, SO17 1BJ, U.K.

References (42)

Show source-provided references
1. Folkman J. · J. Biol. Chem. · 1992 · 267 · 1093110.1016/S0021-9258(19)49853-0 ↗
2. Carmeliet P. · Nat. Med. · 2003 · 9 · 65310.1038/nm0603-653 ↗
3. Carmeliet P. · Nature · 2000 · 407 · 24910.1038/35025220 ↗
4. Folkman J. · Nat. Med. · 1995 · 1 · 2710.1038/nm0195-27 ↗
5. Goodwin A. M. · Micovasc. Res. · 2007 · 74 · 17210.1016/j.mvr.2007.05.006 ↗
6. Risau W. · Nature · 1997 · 386 · 67110.1038/386671a0 ↗
7. D’Andrea L. D. · Chem. Biol. Drug Des. · 2006 · 67 · 11510.1111/j.1747-0285.2006.00356.x ↗
8. Des Guetz G. · Targ. Oncol. · 2011 · 6 · 19710.1007/s11523-011-0204-7 ↗
9. Chung E. · Nano Today · 2012 · 7 · 51410.1016/j.nantod.2012.10.007 ↗
10. Nichols J. W. · Nano Today · 2012 · 7 · 60610.1016/j.nantod.2012.10.010 ↗
11. Kievit F. M. · Adv. Mater. · 2011 · 23 · H21710.1002/adma.201102313 ↗
12. Banerjee D. · Vasc. Cell · 2011 · 3 · 110.1186/2045-824X-3-3 ↗
13. Bartczak D. · Langmuir · 2010 · 26 · 707210.1021/la9044013 ↗
14. Charron G. · Langmuir · 2012 · 28 · 1514110.1021/la302570s ↗
15. Conde J. · ACS Nano · 2012 · 6 · 831610.1021/nn3030223 ↗
16. Quarta A. · Nanoscale · 2012 · 4 · 331910.1039/c2nr30271c ↗
17. Thanh N. T. K. · Nano Today · 2010 · 5 · 21310.1016/j.nantod.2010.05.003 ↗
18. Lu Z. · Chem. Soc. Rev. · 2012 · 41 · 687410.1039/c2cs35197h ↗
19. Fairbairn N. · Phys. Chem. Chem. Phys. · 2013 · 15 · 416310.1039/C2CP43162A ↗
20. Arvizo R. R. · Chem. Soc. Rev. · 2012 · 41 · 294310.1039/c2cs15355f ↗
21. Dreaden E. C. · Chem. Soc. Rev. · 2012 · 41 · 274010.1039/C1CS15237H ↗
22. Rosman C. · Small · 2012 · 8 · 368310.1002/smll.201200853 ↗
23. Rodríguez-Lorenzo L. · Integr. Biol. · 2011 · 9 · 92210.1039/c1ib00029b ↗
24. Halas N. J. · Chem. Rev. · 2011 · 111 · 391310.1021/cr200061k ↗
25. Bhattacharya R. · Adv. Drug Delivery Rev. · 2008 · 60 · 128910.1016/j.addr.2008.03.013 ↗
26. Kim J. H. · Biomaterials · 2011 · 32 · 186510.1016/j.biomaterials.2010.11.030 ↗
27. Patra C. R. · Toxicol. Appl. Pharmacol. · 2009 · 249 · 8810.1016/j.taap.2009.07.009 ↗
28. Patra C. R. · Adv. Mater. · 2008 · 20 · 75310.1002/adma.200701611 ↗
29. Mukherjee P. · Clin. Cancer Res. · 2005 · 11 · 353010.1158/1078-0432.CCR-04-2482 ↗
30. Bhattacharya R. · Nano Lett. · 2004 · 4 · 247910.1021/nl0483789 ↗
31. Arvizo R. R. · Nanomed.: Nanotechnol., Biol., Med. · 2011 · 7 · 58010.1016/j.nano.2011.01.011 ↗
32. Bartczak D. · Nanoscale · 2012 · 4 · 447010.1039/c2nr31064c ↗
33. Bartczak D. · Small · 2012 · 8 · 12210.1002/smll.201101422 ↗
34. Bartczak D. · Nano Lett. · 2011 · 11 · 135810.1021/nl104528s ↗
35. Bartczak D. · Small · 2011 · 7 · 38810.1002/smll.201001816 ↗
36. Turkevich J. · Discuss. Faraday Soc. · 1951 · 11 · 5510.1039/df9511100055 ↗
37. Kanaras A. G. · Chem. Commun. · 2002 · 20 · 229410.1039/b207838b ↗
38. Bartczak D. · Langmuir · 2011 · 27 · 1011910.1021/la2022177 ↗
39. Niemisto A. · IEEE Trans. Med. Imaging · 2005 · 24 · 54910.1109/TMI.2004.837339 ↗
40. Neufeld G. · FASEB J. · 1999 · 13 · 910.1096/fasebj.13.1.9 ↗
41. Murga M. · Blood · 2005 · 105 · 199210.1182/blood-2004-07-2598 ↗
42. Clauss M. · 200510.1007/b137088 ↗